Lite Strategy, Inc. (LITS)

NASDAQ: LITS · Real-Time Price · USD

1.130

-0.010 (-0.88%)

Feb 27, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Development of Pharmaceutical Products		65.30M	48.82M	40.70M	34.80M	27.76M
Development of Pharmaceutical Products Growth		33.76%	19.95%	16.96%	25.36%	464.72%
Total		65.30M	48.82M	40.70M	34.80M	27.76M
Total Growth		33.76%	19.95%	16.96%	25.36%	464.72%

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
United States of America		65.30M	48.82M	40.70M	34.80M	27.76M
United States of America Growth		33.76%	19.95%	16.96%	25.36%	464.72%
Total		65.30M	48.82M	40.70M	34.80M	27.76M
Total Growth		33.76%	19.95%	16.96%	25.36%	464.72%

Source: S&P Global Market Intelligence.